NDC 31722-504

Efavirenz

Efavirenz

Efavirenz is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Efavirenz.

Product ID31722-504_6d625901-fef2-4c93-9619-f8991d65413d
NDC31722-504
Product TypeHuman Prescription Drug
Proprietary NameEfavirenz
Generic NameEfavirenz
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-04-27
Marketing CategoryANDA / ANDA
Application NumberANDA078886
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameEFAVIRENZ
Active Ingredient Strength600 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 31722-504-25

250 TABLET, FILM COATED in 1 BOTTLE (31722-504-25)
Marketing Start Date2018-04-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 31722-504-30 [31722050430]

Efavirenz TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078886
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-27

NDC 31722-504-25 [31722050425]

Efavirenz TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA078886
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-27

Drug Details

Active Ingredients

IngredientStrength
EFAVIRENZ600 mg/1

OpenFDA Data

SPL SET ID:6d625901-fef2-4c93-9619-f8991d65413d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349477
  • UPC Code
  • 0331722504300
  • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]

    Medicade Reported Pricing

    31722050430 EFAVIRENZ 600 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Efavirenz" or generic name "Efavirenz"

    NDCBrand NameGeneric Name
    0378-2233Efavirenzefavirenz
    31722-504EfavirenzEfavirenz
    42543-889EfavirenzEfavirenz
    51407-382EfavirenzEfavirenz
    64380-889EfavirenzEfavirenz
    64980-406EfavirenzEfavirenz
    64980-407EfavirenzEfavirenz
    65862-049EfavirenzEfavirenz
    65862-104EfavirenzEfavirenz
    69097-301EfavirenzEfavirenz
    70518-1100EfavirenzEfavirenz
    70518-1013EfavirenzEfavirenz
    65862-105EfavirenzEfavirenz
    65862-106EfavirenzEfavirenz
    65862-774EfavirenzEfavirenz
    0056-0470SUSTIVAEfavirenz
    0056-0474SUSTIVAefavirenz
    0056-0510SUSTIVAefavirenz

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.